Study to Evaluate the Efficacy and Safety of Ampligen in Patients With Post-COVID Conditions
Status:
Not yet recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Ampligen® administered
twice weekly by intravenous (IV) infusions in subjects experiencing the Post-COVID Condition
of fatigue.